The research team included, back row, from left, Shih-I (Harry) Tan, Nilmani Singh, Aashutosh Boob, and front row, from left, Teresa Martin, Li-Qing Chen, and Huimin Zhao. The mitochondrion, often ...
Targeted inhibition of a "signal jammer" protein may improve how tumors respond to immunotherapy. Published today in Nature, a new study demonstrates how some cancer cells use the protein ...
Phase I and pharmacokinetics study of a novel anti-CD20 antibody, RO5072759 (GA101), in Japanese patients (Pts) with relapsed or refractory B-cell non-Hodgkin lymphoma (B-NHL) pretreated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback